Brighton, MA, United States of America

Tyler Mann

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Tyler Mann

Introduction

Tyler Mann, an accomplished inventor based in Brighton, MA, has made significant strides in pharmaceutical innovation. With a remarkable portfolio consisting of five patents, his work emphasizes the development of antiviral compounds aimed at combating severe respiratory infections.

Latest Patents

Among his latest contributions to the field are patents related to antiviral heterocyclic compounds. These compounds, described by the formula (I) and its pharmaceutically acceptable salts, esters, or prodrugs, are specifically designed to inhibit Human Respiratory Syncytial Virus (HRSV) and Human Metapneumovirus (HMPV). The inventions not only propose these innovative compounds but also outline pharmaceutical compositions intended for treating individuals suffering from HRSV or HMPV infections. Furthermore, Tyler's work details the methods for administering these vital treatments, showcasing his commitment to improving patient outcomes in infectious diseases.

Career Highlights

Tyler Mann currently works at Enanta Pharmaceuticals, Inc., where he collaborates on groundbreaking research aimed at developing effective antiviral treatments. His contributions have been critical in advancing the scientific understanding and therapeutic approaches to viral infections.

Collaborations

Throughout his career, Tyler has partnered with notable colleagues such as Adam Szymaniak and Kevin McGrath, further enriching his innovative endeavors. Their collaborations have facilitated a creative and productive environment that fosters the development of pioneering medical solutions.

Conclusion

In conclusion, Tyler Mann's commitment to innovation in the pharmaceutical arena has established him as a pivotal figure in the fight against viral infections. With multiple patents to his name and ongoing collaborations with esteemed colleagues, his work continues to influence the landscape of antiviral research and pave the way for future advancements in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…